Showing results (381-390 of 420) with videos related to
Sort By:
Pageof 42
Annals of Clinical and Translational Neurology|February 26, 2025
Targeted Long-Read Sequencing as a Single Assay Improves the Diagnosis of Spastic-Ataxia DisordersLaura Ivete Rudaks, Igor Stevanovski, Dennis Yeow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2018
Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 TrialSandro Virgilio Porceddu, Mathias Bressel, Michael Geoffrey Poulsen, et al.Journal of the National Cancer Institute|May 15, 2014
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survivalYin Cao, Sara Lindström, Fredrick Schumacher, et al.The New England Journal of Medicine|November 27, 2014
Age-related clonal hematopoiesis associated with adverse outcomesSiddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.Applied Clinical Informatics|April 6, 2017
The Building Blocks of Interoperability. A Multisite Analysis of Patient Demographic Attributes Available for MatchingAdam Culbertson, Satyender Goel, Margaret B Madden, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Validation of genome-wide prostate cancer associations in men of African descentBao-Li Chang, Elaine Spangler, Stephen Gallagher, et al.European Urology|January 14, 2014
Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumIrene M Shui, Sara Lindström, Adam S Kibel, et al.The Prostate|August 14, 2015
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3)Sarah C Markt, Irene M Shui, Robert H Unger, et al.Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.European Urology|February 3, 2026
Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.Pageof 42